相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TGF-β Increases Glioma-Initiating Cell Self-Renewal through the Induction of LIF in Human Glioblastoma
Silvia Penuelas et al.
CANCER CELL (2009)
Site-specific anti-tumor immunity: Differences in DC function, TGF-β production and numbers of intratumoral Foxp3+ Treg
Gregoire Biollaz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Accessing the therapeutic potential of immunostimulatory nucleic acids
Winfried Barchet et al.
CURRENT OPINION IN IMMUNOLOGY (2008)
Brain tumor therapy by combined vaccination and antisense oligonucleotide delivery with nanoparticles
Thomas Schneider et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Rudy Juliano et al.
NUCLEIC ACIDS RESEARCH (2008)
Microglia-derived TGF-β as an important regulator of glioblastoma invasion -: an inhibition of TGF-β-dependent effects by shRNA against human TGF-β type II receptor
A. Wesolowska et al.
ONCOGENE (2008)
The role of versican isoforms V0/V1 in glioma migration mediated by transforming growth factor-β2
F. Arslan et al.
BRITISH JOURNAL OF CANCER (2007)
High TGFβ-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene
Alejandra Bruna et al.
CANCER CELL (2007)
Inhibition of TGF-beta 2 with AP 12009 in recurrent malignant gliomas: From preclinical to phase I/II studies
Peter Hau et al.
OLIGONUCLEOTIDES (2007)
TGF-beta 2 inhibition augments the effect of tumor vaccine and improves the survival of animals with pre-established brain tumors
Yang Liu et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Phase I clinical trial of a TGF-β antisense-modified tumor cell vaccine in patients with advanced glioma
H. Fakhrai et al.
CANCER GENE THERAPY (2006)
Improving the delivery of therapeutic agents to CNS neoplasms: a clinical review
MA Badruddoja et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Targeted tumor therapy with the TGF-β2 antisense compound AP 12009
KH Schlingensiepen et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Transforming growth factor-beta: A molecular target for the future therapy of glioblastoma
W Wick et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma
A Carpentier et al.
NEURO-ONCOLOGY (2006)
TGF-β directly targets cytotoxic T cell functions during tumor evasion of immune surveillance
DA Thomas et al.
CANCER CELL (2005)
Convection-enhanced drug delivery: Increased efficacy and magnetic resonance image monitoring
Y Mardor et al.
CANCER RESEARCH (2005)
Safety and feasibility of convection-enhanced delivery of cotara for the treatment of malignant glioma: Initial experience in 51 patients
SJ Patel et al.
NEUROSURGERY (2005)
Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: Toxicology and safety
R Schlingensiepen et al.
OLIGONUCLEOTIDES (2005)
Efficacy and toxicity of the antisense oligonucleotide aprinocarsen directed against protein kinase C-alpha delivered as a 21-day continuous intravenous infusion in patients with recurrent high-grade astrocytomas
SA Grossman et al.
NEURO-ONCOLOGY (2005)
Development of TGF-β signalling inhibitors for cancer therapy
JM Yingling et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Toxicology of antisense therapeutics
TLH Jason et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
SD-208, a novel transforming growth factor β receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo
M Uhl et al.
CANCER RESEARCH (2004)
Targeted therapy for malignant gliomas
AP Morokoff et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2004)
Convection-enhanced delivery of tumor necrosis factor-related apoptosis-inducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model
R Saito et al.
CANCER RESEARCH (2004)
Extensive distribution of liposomes in rodent brains and brain tumors following convection-enhanced delivery
C Mamot et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Safety and efficacy of convection-enhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats
JW Degen et al.
JOURNAL OF NEUROSURGERY (2003)
Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma
J Voges et al.
ANNALS OF NEUROLOGY (2003)
TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression
BW Tang et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Progress report of a Phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-α and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors
JH Sampson et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Making sense of latent TGFβ activation
JP Annes et al.
JOURNAL OF CELL SCIENCE (2003)
TGF-β signaling:: positive and negative effects on tumorigenesis
LM Wakefield et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2002)
TGF-β signaling in tumor suppression and cancer progression
R Derynck et al.
NATURE GENETICS (2001)
Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain
JB Nguyen et al.
NEUROREPORT (2001)
Differential expression of transforming growth factors-beta 1, -beta 2 and -beta 3 in human colon carcinoma
G Bellone et al.
EUROPEAN JOURNAL OF CANCER (2001)
The transforming growth factor-βs:: Structure, signaling, and roles in nervous system development and functions
M Böttner et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Transforming growth factors β1 (TGF-β1) and TGF-β2 promote glioma cell migration via up-regulation of αvβ3 integrin expression
M Platten et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo
G Hartmann et al.
JOURNAL OF IMMUNOLOGY (2000)
Antisense oligonucleotides in cancer - Recent advances
IV Lebedeva et al.
BIODRUGS (2000)
分享论文
